Cardano Risk Management B.V. lowered its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 2.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 747,768 shares of the company’s stock after selling 17,566 shares during the quarter. Procter & Gamble accounts for about 1.9% of Cardano Risk Management B.V.’s portfolio, making the stock its 16th largest position. Cardano Risk Management B.V.’s holdings in Procter & Gamble were worth $125,363,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of PG. Fiera Capital Corp lifted its position in Procter & Gamble by 1,135.1% during the second quarter. Fiera Capital Corp now owns 20,688 shares of the company’s stock valued at $3,412,000 after purchasing an additional 19,013 shares during the last quarter. Quest Partners LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter worth about $36,000. Oppenheimer Asset Management Inc. lifted its holdings in shares of Procter & Gamble by 10.6% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 91,768 shares of the company’s stock worth $15,134,000 after acquiring an additional 8,828 shares during the last quarter. Inspire Advisors LLC lifted its holdings in Procter & Gamble by 16.5% during the 2nd quarter. Inspire Advisors LLC now owns 1,813 shares of the company’s stock valued at $299,000 after buying an additional 257 shares in the last quarter. Finally, Lyell Wealth Management LP lifted its holdings in Procter & Gamble by 11.6% during the 2nd quarter. Lyell Wealth Management LP now owns 4,386 shares of the company’s stock valued at $723,000 after buying an additional 457 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Up 0.1 %
Shares of NYSE PG traded up $0.18 during mid-day trading on Monday, hitting $158.74. The company had a trading volume of 2,259,233 shares, compared to its average volume of 6,193,444. The Procter & Gamble Company has a 1-year low of $146.28 and a 1-year high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The company has a market capitalization of $373.84 billion, a PE ratio of 27.37, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The business’s 50-day simple moving average is $169.64 and its 200 day simple moving average is $169.61.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the transaction, the insider now owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. This trade represents a 52.47 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO R. Alexandra Keith sold 1,992 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 75,439 shares of company stock worth $13,317,460 over the last ninety days. Corporate insiders own 0.18% of the company’s stock.
Analysts Set New Price Targets
Several brokerages recently weighed in on PG. DA Davidson restated a “buy” rating and set a $209.00 target price on shares of Procter & Gamble in a research note on Friday, December 27th. Piper Sandler assumed coverage on Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. JPMorgan Chase & Co. boosted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Finally, Evercore ISI boosted their price objective on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $179.75.
Read Our Latest Stock Analysis on PG
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- How to Use Stock Screeners to Find Stocks
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What Are Some of the Best Large-Cap Stocks to Buy?
- Delta Can Fly to New Highs in 2025; Here’s Why
- What is the Euro STOXX 50 Index?
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.